A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Sep 15, 2020
0
91
There are 102 candidate vaccines being explored as a means of ending the COVID-19 pandemic, as of April 30. Eight of these have already made it to clinical trials in humans, and another 94 are in the pre-clinical evaluation ...
May 13, 2020
0
7
After cities shut down and citizens were urged to stay home to slow the spread of COVID-19, scientists in major cities like Boston were suddenly far removed from their labs. At MIT, on-campus research was ramped down, reduced ...
Apr 23, 2020
0
4
(HealthDay)—The recombinant influenza vaccine (RIV4) is well tolerated in children aged 6 to 17 years, and it provides immunogenicity comparable to that of the inactivated vaccine, according to a study published online ...
Apr 2, 2018
0
2
A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine ...
Nov 2, 2017
0
2
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.
Jul 24, 2017
0
1
A vital race is on in laboratories across the globe to develop a vaccine for the Zika virus. However, even if a vaccine were available today, many of the world's poorest people would not be able to receive it due to political ...
Feb 8, 2017
0
0
As scientists race to create a vaccine for the Zika virus, new research from the University of Georgia suggests almost half of Americans wouldn't be interested in getting the shot even if public health officials recommended ...
Dec 14, 2016
0
0
(HealthDay)—A combination vaccine offered to mothers from 28 weeks of gestation may offer protection for infants born prematurely, according to a study published online June 2 in Pediatrics.
Jun 6, 2016
0
1
No one worries about vaccine supply—until there's a shortage. New research from Duke University's Fuqua School of Business studied the market tensions that can keep manufacturers out of the business and the price points ...
Feb 10, 2016
0
20
